We are Sorry, This Page doesn't Exist
Merck"s stock gains after profit and sales beat, but outlook is downbeat
Shares of Merck & Co. Inc. rose 1% in premarket trading Tuesday, after the drug giant reported first-quarter profit and sales that beat expectations, but provided a downbeat full-year outlook. Net income rose to $3.22 billio.....»»
Market Snapshot: Dow, S&P and Nasdaq rise as year-end holiday rally takes stocks to record heights
U.S. stocks are adding to record gains on Friday as investors attempt to close out a holiday-shortened week on a powerful up trend, a day after a report on strong retail sales helped the Nasdaq to finish above 9,000 for the first time......»»
Market Snapshot: Dow poised to extend climb as year-end holiday rally takes stocks to record heights
U.S. stock indexes on Friday are on track to add to record gains as investors attempt to close out a holiday-shortened week on a powerful up trend, a day after a report on strong retail sales helped the Nasdaq to finish above 9,000 for the first time......»»
Nasdaq tops 9,000 on Amazon; U.S.-China trade optimism drives record rally
The Nasdaq topped the 9,000-point mark for the first time on Thursday and the S&P 500 hit a record high, boosted by optimism over U.S.-China trade relations and gains in shares of Amazon.com after a report signaled robust online holiday sales......»»
Aslan"s Rally Grows After Positive Readout From Eczema Drug Study
After soaring 81.25% Wednesday and augmenting the gains by an incremental 65% Friday, ASLAN PHARMACEU/ADR (NASDAQ: ASLN) shares were accelerating further Monday morning. 0 read more.....»»
: Nvidia stock rally loses steam on cloudy outlook for server chips, full-year earnings
Nvidia Corp. shares shed big gains in the extended session Thursday after the graphics-chip maker does not provide a full-year outlook and says that data-center sales would likely remain weak......»»
Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales
Radius Health's (RDUS) lead drug, Tymlos, gains traction in 2018. Let us see how the drug will.....»»
Sarepta"s DMD Portfolio Solid, Sole Drug Dependence Concerns
Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern. On Jul 4, we issued a.....»»
Merck profit beats, but Keytruda sales fail to impress
Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb's Opdivo, but that was not enough for investors who expected bigger gains in market share for the cancer therapy......»»
General Electric"s modest gains, candor spark "relief rally"
General Electric Co beat estimates for sales and cash flow in the fourth quarter and said on Thursday it had reached a tentative deal to settle a subprime mortgage case with U.S. regulators, sending its shares sharply higher......»»
Fall in U.S. retail sales erases world stock market rally
The steepest decline in U.S. retail sales since 2009 in December erased broad gains in world stock markets on Thursday and pushed investors into the safety of government bonds......»»
AutoZone"s stock set to rally after big profit and sales beats
Shares of AutoZone Inc. were indicated up nearly 2% in premarket trading Tuesday, after the aut.....»»
US stocks rally as investors weigh stalling retail sales and inflation guidance
Stocks on Friday rose, pushing past virtually unchanged retail sales for April. Fed officials assured investors this week that it will remain s.....»»
Stocks rally as retail sales weakness taken in stride
U.S. equity markets rallied Friday as traders celebrated the lifting of most mask mandates and digested disappointing retail sales......»»
RealReal posts another quarterly loss, but sales rise
Shares of RealReal Inc. weaved between gains and losses in the extended session Monday after the e-commerce retailer of secondhand luxury goods reported a narrower first-quar.....»»
SVB Leerink upgrades Epizyme, citing sales potential for lymphoma drug
Shares of Epizyme Inc. were up 11.0% in premarket trading on Friday after SVB Leerink upgraded the company's stock to outperform, from market perform, citing Tazverik's potential opportunity in the follicular lymphoma market. Analyst Andrew Berens told.....»»
As Dogecoin Rally Mutes, "Cheaper" Ethereum, Bitcoin Look-Alikes Stike Massive Gains
Dogecoin (DOGE) traded nearly 17% lower on Thursday night at press time as the cryptocurrency took a breather from its recent upwards march, but Ethereum Classic (ETC) and Bitcoin Diamond (BCD) charted a different course. read more.....»»
Dow gains 318 points, Nasdaq rebounds with jobs data Friday
U.S. stocks see a rally across the board ahead of Friday's jobs report......»»
NewsWatch: Stock market peak? ‘Easy money’ has been made but room for more gains, strategists say
The “easy money” stage of the U.S. stock market rally is likely over, but there's still room for gains as economic growth steams ahead in 2021, bullish investors say......»»
Colgate-Palmolive stock gains after profit, sales top expectations
Shares of Colgate-Palmolive Co. edged up 0.2% in premarket trading Friday, after the oral, person and home care and pet nutrition company reported first-quarter profit and sales that topped expectations and provided an in-line full-year outlook. .....»»